SSBP3-AS1
Putative uncharacterized protein SSBP3-AS1
Also known as: SSAS1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for SSBP3-AS1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
100 residues, UniProt reviewed canonical sequence.
>Q7Z2R9|SSBP3-AS1
1 MWGFLVLKAR WLVTPVRTLA TEAGQKPSLR GLLDVGNIQH RAARARGLTR GVIRVSPQER
61 SQQNQSAPKG PTPSTRPKPR TLGPQAHSLA LQSVDLLFRPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SSBP3-AS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- 0.32
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SSBP3-AS1 as an antibody target. Whether an autoantibody or antibody against SSBP3-AS1 could matter depends on whether native SSBP3-AS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SSBP3-AS1 is annotated as secreted, so native SSBP3-AS1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SSBP3-AS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...